NOTICE OF AWARD COMPOUND PHARMACEUTICALS
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of the Army, under the Department of Defense, has issued a Notice of Award for Compound Pharmaceuticals. This award, designated as a Total Small Business Set-Aside, covers the provision of drugs and biologicals, with performance expected at Fort Hood, TX. The awardee and specific contract details are not provided in this notice.
Scope of Work
This award is for Compound Pharmaceuticals, categorized under Product Service Code 6505 (Drugs And Biologicals). Further details regarding the specific scope of services or supplies are not available in this notice.
Contract & Timeline
- Type: Not specified
- Duration: Not specified
- Value: Not specified
- Set-Aside: Total Small Business Set-Aside (FAR 19.5)
- Award Date: March 3, 2026
Additional Notes
This notice serves as a public record of an award made by the W40M MRC0 WEST office. Interested parties should refer to the original solicitation (if applicable) for comprehensive details, as this award notice does not specify the awardee or contract terms. Primary contact for inquiries is Sheryl Egans at sheryl.j.egans.civ@health.mil.